(PDF) Augmented Antipsychotic Therapy With Pantogam Active

Augmented Antipsychotic Therapy With Pantogam Active in Patients With Schizophrenia

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova - Russian Federation

doi 10.17116/jnevro20151158128-34

Full Text

Abstract

Available in full text

Categories

Date

January 1, 2015

Authors

E. V. Gushanskaya

A. U. Ter-israelyan

Publisher

Media Sphere Publishing Group

Related search

Measurement of Treatment Adherence With Antipsychotic Agents in Patients With Schizophrenia

Neuropsychiatric Disease and Treatment

Biological Psychiatry

English

Morphophenotypic Predictor of the Development of Visceral Obesity in Patients With Schizophrenia Receiving Antipsychotic Therapy

Bulletin of Siberian Medicine

Molecular Medicine

English

Antipsychotic-Free Status in Community-Dwelling Patients With Schizophrenia in China

Journal of Clinical Psychiatry

English

Antipsychotic Patterns of Use in Patients With Schizophrenia: Polypharmacy Versus Monotherapy

English

Increased Orbitofrontal Cortex Activation Associated With “Pro-Obsessive” Antipsychotic Treatment in Patients With Schizophrenia

Journal of Psychiatry and Neuroscience

Biological Psychiatry

English

Evaluation of Paliperidone Palmitate Long‐acting Injectable Antipsychotic Therapy as an Early Treatment Option in Patients With Schizophrenia

Early Intervention in Psychiatry

Psychiatric Mental Health

Biological Psychiatry

English

Treatment Adherence and Social Functioning in Patients Diagnosed With Schizophrenia and Treated With Antipsychotic Depot Medication

Medicine and Pharmacy Reports

English

Erratum To: Association of the ZFPM2 Gene With Antipsychotic-Induced Parkinsonism in Schizophrenia Patients

Psychopharmacology

English

Clinical and Psychosocial Remission in Schizophrenia: Correlations With Antipsychotic Treatment

English